Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doruk Erkan

Showing results (31-40 of 193) with videos related to

Pageof 20
Sort By:
Current Rheumatology Reports|April 20, 2011
Clinical assessment and management of cytopenias in lupus patientsAlana B Levine, Doruk Erkan
Nature Reviews. Rheumatology|March 12, 2014
Therapy: Antiphospholipid syndrome research needs more collaborationDoruk Erkan, Michael D Lockshin
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|March 30, 2016
The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid SyndromeDoruk Erkan, Jane E Salmon
Nature Reviews. Rheumatology|May 3, 2024
Rethinking antiphospholipid syndrome to guide future management and researchJason S Knight, Doruk Erkan
Current Rheumatology Reports|September 21, 2016
AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION): 5-Year UpdateMedha Barbhaiya, Danieli Andrade, Doruk Erkan, et al.
Pain Practice : the Official Journal of World Institute of Pain|July 26, 2017
Cervical Epidural Injection in the Management of Refractory Pain and Stiffness in Spondyloarthropathy: A Case Report SeriesSemih Gungor, Rohit Aiyer, Doruk Erkan
Current Rheumatology Reports|January 26, 2015
The challenge of bleeding in antiphospholipid antibody-positive patientsGiulia Pazzola, Stéphane Zuily, Doruk Erkan
Current Rheumatology Reports|September 12, 2018
Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018?Yu Zuo, Medha Barbhaiya, Doruk Erkan
Rheumatology (Oxford, England)|March 25, 2025
Comment on "ANA-Positive versus ANA-Negative Antiphospholipid Antibody-Positive Patients: Results from the APS ACTION Registry". ReplyIrene Cecchi, Doruk Erkan, Savino Sciascia
European Journal of Rheumatology|October 7, 2016
The clinical significance of antiphospholipid antibodies in systemic lupus erythematosusOzan Ünlü, Stephane Zuily, Doruk Erkan
Pageof 20

Showing results (31-40 of 193) with videos related to

Sort By:
Pageof 20
Current Rheumatology Reports|April 20, 2011
Clinical assessment and management of cytopenias in lupus patientsAlana B Levine, Doruk Erkan
Nature Reviews. Rheumatology|March 12, 2014
Therapy: Antiphospholipid syndrome research needs more collaborationDoruk Erkan, Michael D Lockshin
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|March 30, 2016
The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid SyndromeDoruk Erkan, Jane E Salmon
Nature Reviews. Rheumatology|May 3, 2024
Rethinking antiphospholipid syndrome to guide future management and researchJason S Knight, Doruk Erkan
Current Rheumatology Reports|September 21, 2016
AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION): 5-Year UpdateMedha Barbhaiya, Danieli Andrade, Doruk Erkan, et al.
Pain Practice : the Official Journal of World Institute of Pain|July 26, 2017
Cervical Epidural Injection in the Management of Refractory Pain and Stiffness in Spondyloarthropathy: A Case Report SeriesSemih Gungor, Rohit Aiyer, Doruk Erkan
Current Rheumatology Reports|January 26, 2015
The challenge of bleeding in antiphospholipid antibody-positive patientsGiulia Pazzola, Stéphane Zuily, Doruk Erkan
Current Rheumatology Reports|September 12, 2018
Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018?Yu Zuo, Medha Barbhaiya, Doruk Erkan
Rheumatology (Oxford, England)|March 25, 2025
Comment on "ANA-Positive versus ANA-Negative Antiphospholipid Antibody-Positive Patients: Results from the APS ACTION Registry". ReplyIrene Cecchi, Doruk Erkan, Savino Sciascia
European Journal of Rheumatology|October 7, 2016
The clinical significance of antiphospholipid antibodies in systemic lupus erythematosusOzan Ünlü, Stephane Zuily, Doruk Erkan
Pageof 20